Zhejiang Huakang Pharmaceutical Co., Ltd.
SSE:605077.SS
15.09 (CNY) • At close April 30, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 816.548 | 714.567 | 747.063 | 718.221 | 628.584 | 732.693 | 673.297 | 718.443 | 650.334 | 611.621 | 638.434 | 544.573 | 405.396 | 406.086 | 456.751 | 402.506 | 328.673 | 331.351 | 281.146 | 369.606 | 337.55 | 361.202 | 429.527 |
| Cost of Revenue
| 658.117 | 526.926 | 601.253 | 586.473 | 482.352 | 566.444 | 502.881 | 545.893 | 499.343 | 463.022 | 480.423 | 423.751 | 328.143 | 327.953 | 351.96 | 306.629 | 240.343 | 203.297 | 194.836 | 246.439 | 213.609 | 227.17 | 276.294 |
| Gross Profit
| 158.43 | 187.641 | 145.81 | 131.748 | 146.233 | 166.249 | 170.415 | 172.551 | 150.991 | 148.599 | 158.011 | 120.822 | 77.252 | 78.133 | 104.792 | 95.877 | 88.33 | 128.054 | 86.31 | 123.167 | 123.941 | 134.032 | 153.233 |
| Gross Profit Ratio
| 0.194 | 0.263 | 0.195 | 0.183 | 0.233 | 0.227 | 0.253 | 0.24 | 0.232 | 0.243 | 0.247 | 0.222 | 0.191 | 0.192 | 0.229 | 0.238 | 0.269 | 0.386 | 0.307 | 0.333 | 0.367 | 0.371 | 0.357 |
| Reseach & Development Expenses
| 26.283 | 35.535 | 29.907 | 31.789 | 31.177 | 27.79 | 36.048 | 40.268 | 19.026 | 28.504 | 17.151 | 31.964 | 22.094 | 24.339 | 26.387 | 17.317 | 16.187 | 25.112 | 14.504 | 17.011 | 8.406 | 12.36 | 14.837 |
| General & Administrative Expenses
| 27.514 | -54.049 | 75.994 | -1.611 | 26.145 | -32.087 | 42.562 | -6.741 | 19.603 | -29.149 | 41.425 | -4.224 | 14.393 | -15.469 | 26.179 | -1.786 | 11.789 | 6.479 | -10.487 | -3.41 | 10.269 | -19.29 | 12.264 |
| Selling & Marketing Expenses
| 11.814 | -21.678 | 25.568 | 14.23 | 10.576 | 17.571 | 8.485 | 11.106 | 7.739 | 13.221 | 8.38 | 7.888 | 6.315 | 5.213 | 9.7 | 7.508 | 5.341 | 6.375 | 4.49 | 4.682 | 2.896 | 28.585 | 31.749 |
| SG&A
| 39.328 | -68.44 | 52.606 | 52.251 | 38.757 | 44.123 | 51.047 | 4.364 | 27.342 | -15.928 | 49.805 | 3.664 | 20.707 | -10.257 | 35.879 | 5.722 | 17.129 | 12.854 | -5.997 | 1.272 | 13.165 | 9.294 | 44.013 |
| Other Expenses
| 5.173 | 104.296 | 14.541 | 0.004 | -0.336 | -1.822 | 7.224 | -10.03 | 0.778 | 47.628 | -21.441 | 15.175 | -1.946 | -0.992 | 0.733 | -2.156 | -0.159 | -3.198 | -0.049 | -1.138 | -3.212 | -0.255 | -1.486 |
| Operating Expenses
| 70.784 | 70.725 | 97.054 | 84.037 | 70.271 | 73.735 | 61.99 | 71.447 | 47.146 | 60.203 | 45.514 | 50.804 | 40.855 | 43.356 | 43.47 | 35.497 | 33.762 | 44.183 | 29.933 | 29.987 | 11.549 | 61.429 | 55.821 |
| Operating Income
| 87.646 | 116.916 | 48.756 | 47.711 | 75.962 | 92.514 | 107.15 | 104.594 | 101.979 | 73.043 | 127.681 | 93.692 | 54.815 | 49.973 | 76.869 | 72.643 | 57.159 | 83.626 | 54.298 | 99.312 | 118.879 | 71.617 | 107.751 |
| Operating Income Ratio
| 0.107 | 0.164 | 0.065 | 0.066 | 0.121 | 0.126 | 0.159 | 0.146 | 0.157 | 0.119 | 0.2 | 0.172 | 0.135 | 0.123 | 0.168 | 0.18 | 0.174 | 0.252 | 0.193 | 0.269 | 0.352 | 0.198 | 0.251 |
| Total Other Income Expenses Net
| 1.511 | -23.91 | -1.38 | 12.976 | 9.537 | -0.67 | -0.361 | -3.204 | -1.208 | -4.786 | 0.09 | -0.765 | -0.988 | -0.992 | -1.329 | -0.094 | -0.159 | -3.198 | -0.049 | -1.138 | -3.212 | -0.613 | -1.486 |
| Income Before Tax
| 89.157 | 99.318 | 47.376 | 58.09 | 81.784 | 111.719 | 107.548 | 101.39 | 100.771 | 68.257 | 127.771 | 92.926 | 53.828 | 48.981 | 75.539 | 72.55 | 57 | 80.428 | 54.249 | 98.173 | 115.667 | 71.004 | 106.264 |
| Income Before Tax Ratio
| 0.109 | 0.139 | 0.063 | 0.081 | 0.13 | 0.152 | 0.16 | 0.141 | 0.155 | 0.112 | 0.2 | 0.171 | 0.133 | 0.121 | 0.165 | 0.18 | 0.173 | 0.243 | 0.193 | 0.266 | 0.343 | 0.197 | 0.247 |
| Income Tax Expense
| 7.62 | 11.606 | -1.498 | 2.108 | 5.561 | 15.499 | 17.589 | 6.138 | 10.793 | 3.6 | 15.087 | 1.279 | 3.539 | -4.031 | 7.551 | 8.268 | 5.573 | 7.161 | 5.863 | 18.291 | 10.035 | 7.568 | 13.407 |
| Net Income
| 81.038 | 81.57 | 48.533 | 58.382 | 79.999 | 96.7 | 89.577 | 95.142 | 90.033 | 64.658 | 112.684 | 91.648 | 50.288 | 53.012 | 67.988 | 64.282 | 51.426 | 73.267 | 48.386 | 79.882 | 105.632 | 63.436 | 92.858 |
| Net Income Ratio
| 0.099 | 0.114 | 0.065 | 0.081 | 0.127 | 0.132 | 0.133 | 0.132 | 0.138 | 0.106 | 0.177 | 0.168 | 0.124 | 0.131 | 0.149 | 0.16 | 0.156 | 0.221 | 0.172 | 0.216 | 0.313 | 0.176 | 0.216 |
| EPS
| 0.27 | 0.18 | 0.17 | 0.2 | 0.35 | 0.42 | 0.39 | 0.42 | 0.39 | 0.28 | 0.69 | 0.56 | 0.22 | 0.5 | 0.5 | 0.47 | 0.38 | 0.59 | 0.28 | 0.65 | 0.62 | 0.52 | 0.54 |
| EPS Diluted
| 0.22 | 0.15 | 0.11 | 0.17 | 0.28 | 0.42 | 0.39 | 0.42 | 0.39 | 0.28 | 0.69 | 0.56 | 0.22 | 0.49 | 0.5 | 0.47 | 0.38 | 0.59 | 0.28 | 0.65 | 0.62 | 0.52 | 0.54 |
| EBITDA
| 104.765 | 212.325 | 54.708 | 114.368 | 139.767 | 167.811 | 163.141 | 152.732 | 146.215 | 97.053 | 157.393 | 97.281 | 54.671 | 66.806 | 95.837 | 90.385 | 77.076 | 83.648 | 56.673 | 109.108 | 127.691 | 74.326 | 119.902 |
| EBITDA Ratio
| 0.128 | 0.297 | 0.073 | 0.159 | 0.222 | 0.229 | 0.242 | 0.213 | 0.225 | 0.159 | 0.247 | 0.179 | 0.135 | 0.165 | 0.21 | 0.225 | 0.235 | 0.252 | 0.202 | 0.295 | 0.378 | 0.206 | 0.279 |